公众号 / 文章呼吸衰竭与机械通气重症综合管理与镇静镇痛

体外二氧化碳清除治疗专用连接管的设计

[Design of a dedicated connecting tube for extracorporeal carbon dioxide removal therapy].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论一种获国家实用新型专利的ECCO2R专用连接管,可达到400-500 mL/min血流量,保障治疗效应。

体外二氧化碳清除(ECCO2R)模拟静脉-静脉体外膜氧合模式,以较低血流量清除二氧化碳、纠正高碳酸血症,其清除效果取决于血流量、气流量、膜肺表面积及跨膜二氧化碳分压梯度。目前临床气体交换器表面积一般小于1 m²,保证目标血流量对疗效至关重要,但现有导管无法提供400-500 mL/min血流量,需技术改进。东南大学附属中大医院重症医学科医务人员设计了一种ECCO2R专用连接管,获国家实用新型专利(ZL 2023 2 2120568.4)。该管主体由三根中心静脉导管呈Y形排列构成,导管1与导管2并联后与导管3串联,导管1和2前端接头配无菌保护帽,导管3后端配膜肺接头,导管1和2外侧各附独立侧管用于连接冲洗液、引流段泄压及缩短ECCO2R期间体外循环暂停时间,各导管及侧管均装夹钳。该专用连接管结构简单、操作方便、实用性强,改进后可达400-500 mL/min血流量,保障ECCO2R治疗效果,适合临床推广。

要点

  • ECCO2R清除效果取决于血流量、气流量、膜肺表面积及跨膜二氧化碳分压梯度,临床气体交换器表面积一般小于1 m²,保证目标血流量对疗效至关重要。
  • 现有临床导管无法提供400-500 mL/min血流量,需技术改进;该专用连接管改进后可达400-500 mL/min。
  • 该连接管主体为三根中心静脉导管呈Y形排列:导管1与导管2并联后与导管3串联,导管3后端配膜肺接头连接膜肺。
  • 导管1和2前端接头配无菌保护帽;导管1和2外侧各附独立侧管,用于连接冲洗液、引流段泄压及缩短ECCO2R期间体外循环暂停时间。
  • 导管1、导管2、导管3及侧管均安装夹钳;该管结构简单、操作方便、实用性强,适合临床推广。

适用人群与场景

  • 需要体外二氧化碳清除(ECCO2R)治疗以清除二氧化碳、纠正高碳酸血症的患者。

处置流程与药物剂量

  • 该ECCO2R专用连接管主体由三根中心静脉导管呈Y形排列构成:中心静脉导管1、中心静脉导管2和中心静脉导管3。
  • 导管1与导管2并联,并与导管3串联。
  • 导管1和导管2前端接头配无菌保护帽;导管3后端配膜肺接头,用于连接膜肺。
  • 导管1和导管2外侧各附独立侧管,用于连接冲洗液、引流段泄压及缩短ECCO2R期间体外循环暂停时间。
  • 导管1、导管2、导管3及侧管均安装夹钳。

研究设计与关键结果

  • 该专用连接管由东南大学附属中大医院重症医学科医务人员设计,获国家实用新型专利(ZL 2023 2 2120568.4)。
  • 改进后的连接管可达到400-500 mL/min血流量,保障ECCO2R治疗效果,适合临床推广。

证据类型、等级与局限

  • 证据类型:技术设计与专利描述(国家实用新型专利ZL 2023 2 2120568.4)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 该专用连接管改进后可达400-500 mL/min血流量,弥补现有临床导管无法提供该血流量的不足,从而保障ECCO2R治疗效果。
  • 侧管设计可用于连接冲洗液、引流段泄压及缩短ECCO2R期间体外循环暂停时间。
  • 作者认为该连接管结构简单、操作方便、实用性强,适合临床推广。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Extracorporeal carbon dioxide removal (ECCO2R) is a type of extracorporeal circulation technology. It generally refers to a technique that mimics the modality of veno-venous extracorporeal membrane oxygenation (VV-ECMO), aiming to eliminate carbon dioxide from the blood and correct hypercapnia with a relatively low blood flow. The removal efficacy of ECCO2R depends on blood flow, gas flow rate, membrane lung surface area, and the partial pressure gradient of carbon dioxide (PCO2) across the membrane. Currently, the surface area of gas exchangers used in clinical practice is generally less than 1 m2. Therefore, ensuring the achievement of the target blood flow during ECCO2R therapy is crucial to its effectiveness. However, the catheters currently available in clinical settings fail to deliver a blood flow of 400-500 mL/min, necessitating technical improvements. To address this clinical challenge, the medical staff of critical care medicine department of Zhongda Hospital, Southeast University designed a dedicated connecting tube for ECCO2R therapy, which has been granted a National Utility Model Patent of China (ZL 2023 2 2120568.4). The main structure of this dedicated tube comprises three central venous catheters arranged in a Y shape: central venous catheter 1, central venous catheter 2, and central venous catheter 3. Catheters 1 and 2 are connected in parallel, and in series with catheter 3. The front-end connectors of catheters 1 and 2 are fitted with sterile protective caps, while the rear end of catheters 3 is equipped with a membrane lung connector for connection to the membrane lung. Separate side tubes are attached to the outer sides of catheter 1 and catheter 2 respectively, for connecting irrigation fluid, releasing pressure in the blood drainage segment, and shortening the pause time of extracorporeal circulation during ECCO2R. Clamps are installed on the catheter 1, catheter 2, catheter 3, and the side tubes. The dedicated connecting tube for ECCO2R features a simple in structure, easy to operate, and highly practical. The improved connecting tube can achieve a blood flow of 400-500 mL/min, which ensures the therapeutic effect of ECCO2R and renders it suitable for clinical promotion.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xu B, Qian S, Wang L, et al. [Design of a dedicated connecting tube for extracorporeal carbon dioxide removal therapy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41833356. doi:10.3760/cma.j.cn121430-20240923-00464

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。